Velocity Clinical Research- Binghamton — Vestal, New York

Velocity Clinical Research- Binghamton is a clinical research site located in Vestal, New York, United States 13850.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Velocity Clinical Research- Binghamton has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Obesity.

Sponsors: Amgen.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Vestal

Browse all research sites in New York · View every site in Vestal

• Sacco Eye Group
• Velocity Clinical Research-Vestal
• Meridian Clinical Research LLC
• Velocity Clinical Research
• Research Site
• Sacco Eye Group PLLC
• Saccco Eye Group
• Susquehanna Eye Care
• Bausch Site 13
• 205.452.01151 Boehringer Ingelheim Investigational Site
• Valeant Site 09
• Bausch Site 14

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Velocity Clinical Research- Binghamton?

Velocity Clinical Research- Binghamton has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Velocity Clinical Research- Binghamton conducted?

Velocity Clinical Research- Binghamton has 1 clinical trials on record, with 1 currently active. Their work covers Obesity.

Is Velocity Clinical Research- Binghamton accredited by Crixeo Clinical Trials?

Velocity Clinical Research- Binghamton has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Velocity Clinical Research- Binghamton?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.